Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Other ORP type . 2024
License: CC BY
Data sources: ZENODO
ZENODO
Other ORP type . 2024
License: CC BY
Data sources: Datacite
ZENODO
Other ORP type . 2024
License: CC BY
Data sources: Datacite
versions View all 2 versions
addClaim

Tutelas en Salud y paradoja de los Medicamentos de Marca versus los Medicamentos Genéricos en Colombia

Authors: Andia, Tatiana;

Tutelas en Salud y paradoja de los Medicamentos de Marca versus los Medicamentos Genéricos en Colombia

Abstract

El documento aborda la problemática de las tutelas en Colombia, un mecanismo legal que permite a los ciudadanos reclamar sus derechos constitucionales, especialmente en el ámbito de la salud. En los últimos años, ha habido un aumento significativo en el litigio relacionado con el derecho a la salud, lo que ha generado sobrecostos para el sistema de salud, particularmente en la demanda de medicamentos de marca, que pueden costar hasta diez veces más que los genéricos. A pesar de las reformas propuestas, como la implementación de "Mi Plan", que busca incluir una gama más amplia de servicios y tratamientos, persiste la tensión entre la protección del derecho a la salud y la sostenibilidad financiera del sistema. El documento sugiere que se requiere una política efectiva de promoción del uso de genéricos, regulación de precios y una revisión judicial de las decisiones sobre medicamentos para abordar esta crisis de manera integral.

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average